Search research articles
Contact Us
Filters
Showing results (71-80 of 245) with videos related to
Page
of 25
Sort By:
Lancet (London, England)
|
September 19, 2003
Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme
Marc A Pfeffer, Karl Swedberg, Christopher B Granger, et al.
European Heart Journal
|
November 13, 2008
Impact of hospitalization for acute coronary events on subsequent mortality in patients with chronic heart failure
Putte Abrahamsson, Joanna Dobson, Christopher B Granger, et al.
JACC. Heart Failure
|
May 30, 2020
Use of the Win Ratio in Cardiovascular Trials
João Pedro Ferreira, Pardeep S Jhund, Kévin Duarte, et al.
Journal of the American Heart Association
|
June 15, 2026
Three-Year Durability of Radiofrequency Renal Denervation: SPYRAL HTN-ON MED
David E Kandzari, Felix Mahfoud, Raymond R Townsend, et al.
European Journal of Heart Failure
|
January 11, 2020
Cardiovascular risk associated with serum potassium in the context of mineralocorticoid receptor antagonist use in patients with heart failure and left ventricular dysfunction
Patrick Rossignol, Kevin Duarte, Nicolas Girerd, et al.
Journal of the American College of Cardiology
|
November 18, 2017
Predicting Subclinical Atherosclerosis in Low-Risk Individuals: Ideal Cardiovascular Health Score and Fuster-BEWAT Score
Juan Miguel Fernández-Alvira, Valentín Fuster, Stuart Pocock, et al.
Journal of the American College of Cardiology
|
December 16, 2017
Normal LDL-Cholesterol Levels Are Associated With Subclinical Atherosclerosis in the Absence of Risk Factors
Leticia Fernández-Friera, Valentín Fuster, Beatriz López-Melgar, et al.
European Journal of Heart Failure
|
January 27, 2009
Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program
Larry A Allen, G Michael Felker, Stuart Pocock, et al.
Journal of Hypertension
|
June 28, 2019
Associations between change in blood pressure and functional outcome, early events and death: results from the Efficacy of Nitric Oxide in Stroke trial
Else C Sandset, Jason P Appleton, Eivind Berge, et al.
Circulation. Cardiovascular Interventions
|
May 20, 2025
Long-Term Safety and Efficacy of Renal Denervation: 24-Month Results From the SPYRAL HTN-ON MED Trial
David E Kandzari, Felix Mahfoud, Raymond R Townsend, et al.
Page
of 25
Search research articles
Search
Showing results (71-80 of 245) with videos related to
Sort By:
Page
of 25
Lancet (London, England)
|
September 19, 2003
Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme
Marc A Pfeffer, Karl Swedberg, Christopher B Granger, et al.
European Heart Journal
|
November 13, 2008
Impact of hospitalization for acute coronary events on subsequent mortality in patients with chronic heart failure
Putte Abrahamsson, Joanna Dobson, Christopher B Granger, et al.
JACC. Heart Failure
|
May 30, 2020
Use of the Win Ratio in Cardiovascular Trials
João Pedro Ferreira, Pardeep S Jhund, Kévin Duarte, et al.
Journal of the American Heart Association
|
June 15, 2026
Three-Year Durability of Radiofrequency Renal Denervation: SPYRAL HTN-ON MED
David E Kandzari, Felix Mahfoud, Raymond R Townsend, et al.
European Journal of Heart Failure
|
January 11, 2020
Cardiovascular risk associated with serum potassium in the context of mineralocorticoid receptor antagonist use in patients with heart failure and left ventricular dysfunction
Patrick Rossignol, Kevin Duarte, Nicolas Girerd, et al.
Journal of the American College of Cardiology
|
November 18, 2017
Predicting Subclinical Atherosclerosis in Low-Risk Individuals: Ideal Cardiovascular Health Score and Fuster-BEWAT Score
Juan Miguel Fernández-Alvira, Valentín Fuster, Stuart Pocock, et al.
Journal of the American College of Cardiology
|
December 16, 2017
Normal LDL-Cholesterol Levels Are Associated With Subclinical Atherosclerosis in the Absence of Risk Factors
Leticia Fernández-Friera, Valentín Fuster, Beatriz López-Melgar, et al.
European Journal of Heart Failure
|
January 27, 2009
Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program
Larry A Allen, G Michael Felker, Stuart Pocock, et al.
Journal of Hypertension
|
June 28, 2019
Associations between change in blood pressure and functional outcome, early events and death: results from the Efficacy of Nitric Oxide in Stroke trial
Else C Sandset, Jason P Appleton, Eivind Berge, et al.
Circulation. Cardiovascular Interventions
|
May 20, 2025
Long-Term Safety and Efficacy of Renal Denervation: 24-Month Results From the SPYRAL HTN-ON MED Trial
David E Kandzari, Felix Mahfoud, Raymond R Townsend, et al.
Page
of 25